Hanmi Pharmaceuticals has been granted a patent for a compound that can bind to a globulin Fc region or a physiologically active polypeptide. The invention also includes methods for preparing polypeptide conjugates and physiologically active polypeptide conjugates. GlobalData’s report on Hanmi Pharmaceuticals gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Hanmi Pharmaceuticals, was a key innovation area identified from patents. Hanmi Pharmaceuticals's grant share as of February 2024 was 32%. Grant share is based on the ratio of number of grants to total number of patents.
Polymer compound for binding to globulin fc region
See Also:
A recently granted patent (Publication Number: US11925691B2) discloses a compound selected from a specific formula, stereoisomers, solvates, and pharmaceutically acceptable salts. The compound falls under Formula 1a, with various options listed under Formulae 2a to 2n. This patent aims to protect the use of these compounds for pharmaceutical purposes, highlighting their potential in the field of medicine.
Furthermore, the patent also covers a method for preparing the compound mentioned in the claims. The method involves introducing an amino group at one end of polyethylene glycol, followed by the introduction of R2 at the other end through an amide bond with the amino group. Additionally, an aliphatic hydrocarbon group containing an aldehyde group is introduced at the opposite end of the polyethylene glycol where R2 is attached. This method provides a detailed process for synthesizing the compound, ensuring its reproducibility and potential application in pharmaceutical research and development.
To know more about GlobalData’s detailed insights on Hanmi Pharmaceuticals, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
